Caregen shows partners siRNA delivery platform alongside peptide line

The wire

1. 01Caregen held its Global Partners Meeting 2026 from September 17 to 19, presenting commercialized peptide products, R&D results and Luxidase-based siRNA delivery technology.
2. 02The 25-year-old peptide company is signaling a move beyond skin and beauty peptides into nucleic acid delivery, relevant to anyone tracking peptide platform companies.
3. 03No deal values, partner names or clinical data were disclosed; follow-up discussions with country partners are planned.

From the source

Caregen: siRNA Next After 25 Years of Peptide Technology… Discussing New Product Market Expansion with Global Partners

For biotech companies to expand product sales in overseas markets, the market experience and distribution capabilities of local partners are just as important as technological development. Since product preferences and customer demands vary by country, regional strategies are necessary in the process of translating R&D achievements into actual sales. Caregen, celebrating its 25th anniversary this